Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 67, Issue 3, 2007, Pages 327-336

  Gredal, C ^a   Rosenfalck, A M ^a   Dejgaard, A ^b   Hilsted, J ^c  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Glucose; Insulin; Meal tolerance test; Postprandial period; Type 2 diabetes mellitus

Indexed keywords

C PEPTIDE; GLUCAGON; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESPONSE; INSULIN SENSITIVITY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OUTPATIENT; PANCREAS ISLET BETA CELL; POSTPRANDIAL STATE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCAGON; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; ISLETS OF LANGERHANS; KINETICS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 34247397918     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510601124024     Document Type: Article

References (28)

1. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 1999;354:617-21.
2. Donahue RP, Abbott RD, Reed DM, Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes 1987;36:689-92.
3. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002;25:1845-50.
4. Ceriello A, Bortolotti N, Motz E, et al. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 1998;21:1529-33.
5. Ceriello A, Cavarape A, Martinelli L, et al. The post-prandial state in type 2 diabetes and endothelial dysfunction: effects of insulin aspart. Diabet Med 2004;21:171-5.
6. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-90.
7. Del Prato S, Tiengo A. The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab Res Rev 2001;17:164-74.
8. Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes 1999;48:99-105.
9. Del Prato S. Loss of early insulin secretion leads to postprandial hyperglycaemia. Diabetologia 2003;46 Suppl 1:M2-8.
10. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104:787-94.
11. Turner RC, Mathews DR, Holman RR, Peto J. Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes. Lancet 1982;1:596-8.
12. Mitrakou A. Pathogenesis of hyperglycaemia in type 2 diabetes. Diabetes Obes Metab 2002;4:249-54.
13. Bergman RN, Finegood DT, Kahn SE. The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 2002;32 Suppl 3:35-45.
14. Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res 2005;36:197-209.
15. Scheen AJ, Castillo MJ, Lefebvre PJ. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications. Diabetes Metab 1996;22:397-406.
16. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment - insulin resistance and betacell function from fasting plasma-glucose and insulin concentrations in man. Diabetologia 1985;28:412-19.
17. Owens DR, Dolben J, Jones IR, Birtwell J, Luzio SD. Hormonal and glycaemic responses to serial meals in newly diagnosed non-insulin dependent diabetic patients. Diabetes Metab 1989;15:1-4.
18. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992;15:318-68.
19. Kahn SE. Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001;86:4047-58.
20. Hales CN. The pathogenesis of NIDDM. Diabetologia 1994;37 Suppl 2:S162-8.
21. Godsland IF, Jeffs JA, Johnston DG. Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 2004;47:1157-66.
22. Albarrak AI, Luzio SD, Chassin LJ, et al. Associations of glucose control with insulin sensitivity and pancreatic beta-cell responsiveness in newly presenting type 2 diabetes. J Clin Endocrinol Metab 2002;87:198-203.
23. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 2003;26:881-5.
24. Bonora E, Calcaterra F, Lombardi S, et al. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care 2001;24:2023-9.
25. Park SW, Ihm SH, Yoo HJ, Park JY, Lee KU. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulindependent diabetes mellitus. Diabetes Res Clin Pract 1997;37:165-71.
26. Yoneda H, Ikegami H, Yamamoto Y, et al. Analysis of early-phase insulin responses in nonobese subjects with mild glucose intolerance. Diabetes Care 1992;15:1517-21.
27. Iwasaki Y, Kondo K, Hasegawa H, Oiso Y. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test. Diabetes Res 1994;25:129-37.
28. Leahy JL, Bonner-Weir S, Weir GC. Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 1992;15:442-55.